Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma

Digestive Diseases and Sciences

Volumn 42, Issue 8, 1997, Pages 1652-1659

  Rudi, Jochen ^a   Kolb, Christof ^b   Maiwald, Matthias ^b   Zuna, Ivan ^b   Von Herbay, Axel ^b   Galle, Peter R ^b   Stremmel, Wolfgang ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

Cytotoxin associated protein; Gastric adenocarcinoma; Helicobacter pylori; Vacuolating cytotoxin

Indexed keywords

ANTIBODY;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; IMMUNOBLOTTING; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RISK FACTOR; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0030764244     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018849112533     Document Type: Article

References (50)

1. Parkin DM, Laara E, Muir CS: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184-97, 1988
2. Correa P, Haenszel W: Epidemiology of gastric cancer. In Epidemiology of Cancer of the Digestive Tract. P Correa, W Haenszel (eds). The Hague, M. Nijhoff, 1982, pp 58-84
3. Joossens JV, Geboers J: Diet and environment in the etiology of gastric cancer. In Frontiers in Gastrointestinal Cancer. B Levin, RH Riddell (eds). New York, Elsevier, 1984, pp 168-183
4. Forman D, Newell DG, Fullerton F, Yarnell JGW, Stacey AR, Wald N, Sitas F: Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 302:1302-1305, 1991
5. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ: Gastric adenocarcinoma and Helicobacterpylori infection. J Natl Cancer Inst 83:1734-1739, 1991
6. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orenteich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127-1131, 1991
7. Nomura A, Stemmermann GN, Chyou P-H, Kato I, Perez-Perez GI, Blaser MJ: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132-1136, 1991
8. Hansson L-E, Engstrand L, Nyren O, Evans DJ, Lindgren A, Bergström R, Andersson B, Athlin L, Bendtsen O, Tracz P: Helicobacterpylori infection: Independent risk factor of gastric adenocarcinoma. Gastroenterology 105:1098-1103, 1993
9. The Eurogast Study Group: An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:1359-1362, 1993
10. Taylor DN, Blaser MJ: The epidemiology of Helicobacter pylori infection. Epidemiol Rev 13:42-59, 1991
11. Cover T, Dooley C, Blaser M: Characterisation of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 58:603-610, 1990
12. Phadnis SH, Ilver D, Janzon L, Normark S, Westblom TU: Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun 62:1557-1565, 1994
13. Schmitt W, Haas R: Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: Structural similarities with the IgA protease type of exported protein. Mol Microbiol 12:307-319, 1994
14. Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno RA, Russi M, Quaranta SI: Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis. J Clin Microbiol 27:225-226, 1989
15. Goossens U, Glupczynski Y, Burette A, Lambert J-P, Vlaes L, Butzler J-P: Role of the vacuolating toxin form Helicobacter pylori in the pathogenesis of duodenal and gastric ulcer. Med Microbiol Lett 1:153-159, 1992
16. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N, Rappuoli RI: Molecular characterization of the 12K-kDa immunodominat antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 90:5791-5795, 1993
17. Tummuru MK, Cover TL, Blaser MJ: Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect Immun 61:1799-1809, 1993
18. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ: Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration and gastric pathology. Lancet 59:1264-1270, 1991
19. + Helicobacter pylori strains. J Clin Microbiol 33:1496-1500, 1995
20. Apel I, Jacobs E, Kist M, Bredt W: Antibody response of patients against a 120-kDa surface protein of Campylobacter pylori. Zentralbl Bakteriol Hyg A 268:271-276, 1988
21. Crabtree JE, Wyatt JI, Sobala GM, Tompkins DS, Primrose JN, Morgan AG: Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 34:1339-1343, 1993
22. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A: Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111-2115, 1995
23. Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujiki N: High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int J Cancer 56:56-60, 1994
24. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31-49, 1965
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
26. Feldman RA, Decks JJ, Evans SJW, Helicobacter pylori Serology Study Group: Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Eur J Clin Microbiol Infect Dis 14:428-433, 1995
27. Laemmli UK: Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
28. Pena AS, Endtz HP, Offerhaus GJA, Hoogenboom-Verdegaal A, van Duijn W, de Vargas N, den Hartog G, Kreuning J, van der Reyden J, Mouton RP, Lamers CBHW: Value of serology (ELISA and immunoblotting) for the diagnosis of Campylabacter pylori infection. Digestion 44:131-141, 1989
29. Crabtree JE, Mahony MJ, Taylor JD, Heatley RV, Littlewood JM, Tompkins DS: Immune responses to Helicobacter pylori in children with recurrent abdominal pain. J Clin Pathol 44:768-771, 1991
30. ™ User's Guide for Personal Computers. Version 6.03, Cary, (North Carolina), SAS Institute, 1988, 1028 pp
31. Rudi J, Müller M, von Herbay A, Zuna I, Raedsch R, Stremmel W, Räth U: Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence. Scand J Gastroenterol 30:958-963, 1995
32. Weel JFL, van der Hulst RWM, Gerrits Y, Roorde P, Feller M, Dankert J, Tytgat GNJ, van der Ende A. The interrelationsship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 173:1171-1175, 1996
33. Cover TL, Cao P, Lind C, Tham KT, Blaser MJ: Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 61:5008-5012, 1993
34. Correa P. Human gastric carcinogenesis: A multistep and multifuctorial process - First American Cancer Society lecture on cancer epidemiology and prevention. Cancer Res 52:6735-6740, 1992
35. Fox JG, Correa P, Taylor NS, Thompson N, Fontham E, Janney F, Sobhan M, Ruiz B, Hunter F: High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol 87:1554-1560, 1992
36. Atherton JC, Cao P, Peck RM, Tummuru MKR, Blaser MJ, Cover TL: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 270:17771-17777, 1995
37. Sipponen P, Kosunen TU, Valle J, Riihela M, Seppala K: Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 33:1029-1032, 1992
38. Parsonnet J, Vandersteen D, Goales J, Sihley RK, Pritikin J, Chang Y: Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 83:640-643, 1991
39. Loffeld RJLF, Willems I, Flendrig JA, Arends JW: Helicobacter pylori and gastric carcinoma. Histopathology 17:537-541, 1990
40. Asaka M, Kimura T, Kato M, Kudo K, Miki K, Ogoshi K, Kato T, Tatsuta M, Graham OY: Possible role of Helicobacter infection in early gastric cancer development. Cancer 73:2691-2694, 1994
41. Endo S, Ohkusa T, Saito Y, Fujiki K, Okayasu I, Sato C: Detection of Helicobacter pylori infection in early stage gastric cancer. Cancer 75:2203-2208, 1995
42. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC: Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437-439, 1994
43. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, Northfield TC: Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 311:711-714, 1995
44. Ponzetto A, La Revere MT, Sanseverion P, Bazzoli F: Association of Helicobacter pylori infection with coronary heart disease. Study confirms previous findings. Br Med J 312:251, 1996 (letter)
45. Delaney BC, Hobbs FDR, Holder R: Association of Helicobacter pylori infection with coronary heart disease. Eradication of the infection on grounds of cardiovascular risk is not supported by current evidence. Br Med J 312:251-252, 1996 (letter)
46. Murray LJ, Bamford KB, O'Reilly DPJ, McCrum EE, Evans AE: Helicobacter pylori: Relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J 74:497-501, 1995
47. McDonagh TA, Woodward M, Morrison C, McMurray J, Tunstall-Pedae H, Lowe GDO, Dargie HJ, McColl KEL: Lack of independent association of H. pylori and coronary heart disease. Gastroenterology 110(suppl):A190, 1996 (abstract)
48. Maier F, Auricchio A, Nilius M, Klein H, Malfertheiner P: Lack of association between Helicobacter pylori infection and angiographically documented coronary heart disease. Gastroenterology 110(suppl):A193, 1996 (abstract)
49. Khursid A, Puetz T, Fenske T, Bajwa T, Vakil N: Seroprevalence of Helicobacter pylori infection in patients with and without angiographic evidence of coronary heart disease. Gastroenterology 110(Suppl):A154, 1996 (abstract)
50. Sandifer Q, Vuilo S, Crompton G: Association of Helicobacter pylori infection with coronary heart disease. Association may not be crucial. Br Med J 312:251. 1996 (letter).